Question 1

Why does device material affect dosing?

Accepted Answer

The elastomer used in many devices absorbs small lipid-soluble molecules into its bulk, so free concentration falls during an experiment and cells receive less than intended. Measure the concentration in the effluent rather than assuming the nominal dose, or use thermoplastic devices and surface coatings that reduce absorption substantially.

Question 2

How should flow rate be chosen?

Accepted Answer

Pick a scaling principle and justify it: matching wall shear stress suits vascular and barrier tissue, while matching medium volume per cell or residence time suits metabolic readouts. These give different flow rates for the same device, so state which was used and what physiological value it was matched against.

Question 3

What readouts establish a working barrier?

Accepted Answer

Electrical resistance measured across the membrane gives continuous monitoring but depends on electrode geometry and temperature, so report the configuration. Pair it with permeability to tracers of different sizes and with imaging of junction proteins, since resistance can appear adequate while localised gaps remain.

Question 4

Which cells should populate the device?

Accepted Answer

Immortalised lines are convenient and reproducible but often lack transporter and metabolic activity. Primary cells behave more faithfully with limited supply and donor variability, while cells derived from reprogrammed lines allow patient-specific work at the cost of immaturity. State donor numbers and passage, since these drive much of the variability observed.

Question 5

What does qualification require?

Accepted Answer

Test a panel of reference substances with established human outcomes, including substances that animal studies mispredicted, and report sensitivity and specificity rather than selected successes. Demonstrate reproducibility across chips, operators and cell batches, because a system that performs well only in one pair of hands has limited value.

Question 6

What complicates linking several chips together?

Accepted Answer

Shared medium must support every tissue at once, which usually means compromising on components each prefers. Relative tissue sizes and flow splits need a scaling rationale, and bubbles or a failure in one chamber can compromise the whole set. Start with two well-characterised tissues before extending further.

Question 7

How is analysis handled at such small volumes?

Accepted Answer

Effluent volumes are microlitre-scale, so assays must be sensitive and sparing. Pooling across time points, integrated sensors for continuous variables, and mass spectrometry methods optimised for small injections all help. Plan the analytical strategy alongside the device, since a readout requiring more sample than the chip produces cannot be retrofitted.

Biotechnology

Biotechnology

Research Frontiers in Organ-on-Chip Microfluidic Systems